Challenging properties are constraining oral medicines, creating a need for technological fixes. Softgels are a validated solution.
Many biopharmaceutical companies and patients favor convenient and cost-effective orally administered drugs. While the format is preferred, the challenging physicochemical properties of most molecules are constraining the progress of oral medicines, creating a need for delivery technologies that streamline and simplify development.
Softgels are a validated technology for overcoming the challenges. However, complex regulatory compliance, specialized manufacturing processes, and a lack of service providers with the required expertise can slow adoption of the technology. This whitepaper will cover how and why companies can address those barriers, covering topics such as:
- Softgels’ effect on critical formulation challenges
- How the dosage form can improve adherence
- Using softgels to de-risk development and manufacturing
- The value of partnering with a specialist CDMO
Offered Free by: Douglas CDMO
See All Resources from: Douglas CDMO
